SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Matthew Kent, Andrew J. Vickers, A Systematic Literature Review of Life Expectancy Prediction Tools for Patients with Localized Prostate Cancer, The Journal of Urology, 2015, 193, 6, 1938

    CrossRef

  2. You have free access to this content2
    Brenda K. Edwards, Anne-Michelle Noone, Angela B. Mariotto, Edgar P. Simard, Francis P. Boscoe, S. Jane Henley, Ahmedin Jemal, Hyunsoon Cho, Robert N. Anderson, Betsy A. Kohler, Christie R. Eheman, Elizabeth M. Ward, Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer, Cancer, 2014, 120, 9
  3. 3
    A. B. Mariotto, A.-M. Noone, N. Howlader, H. Cho, G. E. Keel, J. Garshell, S. Woloshin, L. M. Schwartz, Cancer Survival: An Overview of Measures, Uses, and Interpretation, JNCI Monographs, 2014, 2014, 49, 145

    CrossRef

  4. 4
    Elizabeth Bayliss, Liza Reifler, Chan Zeng, Deanna McQuillan, Jennifer Ellis, John Steiner, Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity, Journal of Comorbidity, 2014, 4, 1, 29

    CrossRef

  5. 5
    B. A. Rabin, J. L. Ellis, J. F. Steiner, L. Nekhlyudov, E. J. Feuer, B. F. Hankey, L. Cynkin, E. Bayliss, Health-Care Utilization by Prognosis Profile in a Managed Care Setting: Using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC, JNCI Monographs, 2014, 2014, 49, 275

    CrossRef

  6. You have free access to this content6
    Larissa Nekhlyudov, Laura Levit, Arti Hurria, Patricia A. Ganz, Patient-centered, evidence-based, and cost-conscious cancer care across the continuum: Translating the Institute of Medicine report into clinical practice, CA: A Cancer Journal for Clinicians, 2014, 64, 6
  7. 7
    N. Howlader, A. B. Mariotto, S. Woloshin, L. M. Schwartz, Providing Clinicians and Patients With Actual Prognosis: Cancer in the Context of Competing Causes of Death, JNCI Monographs, 2014, 2014, 49, 255

    CrossRef

  8. 8
    E. J. Feuer, B. A. Rabin, Z. Zou, Z. Wang, X. Xiong, J. L. Ellis, J. F. Steiner, L. Cynkin, L. Nekhlyudov, E. Bayliss, B. F. Hankey, The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: Validation in a Managed Care Setting, JNCI Monographs, 2014, 2014, 49, 265

    CrossRef

  9. 9
    Atsuhiko Murata, Kohji Okamoto, Keiji Muramatsu, Shinya Matsuda, Time trend of medical economic outcomes of endoscopic submucosal dissection for gastric cancer in Japan: a national database analysis, Gastric Cancer, 2014, 17, 2, 294

    CrossRef

  10. 10
    Geraldine Navarro, Sara Taroumian, Nashla Barroso, Lewei Duan, Daniel Furst, Tocilizumab in rheumatoid arthritis: A meta-analysis of efficacy and selected clinical conundrums, Seminars in Arthritis and Rheumatism, 2014, 43, 4, 458

    CrossRef

  11. 11
    Sandra Eloranta, Jan Adolfsson, Paul C. Lambert, Pär Stattin, Olof Akre, Therese M-L. Andersson, Paul W. Dickman, How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden, Cancer Causes & Control, 2013, 24, 3, 505

    CrossRef

  12. 12
    Angela B. Mariotto, Zhuoqiao Wang, Carrie N. Klabunde, Hyunsoon Cho, Barnali Das, Eric J. Feuer, Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients, Journal of Clinical Epidemiology, 2013, 66, 12, 1376

    CrossRef